Quick Answer
Xenetic Biosciences, Inc. reported Shares Outstanding of 2.29 million shares for fiscal year 2025.
Xenetic Biosciences, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 2.29M | +48.6% |
| 2024 | 1.54M | +0.1% |
| 2023 | 1.54M | +1.6% |
| 2022 | 1.52M | -88.7% |
| 2021 | 13.44M | +53.7% |
| 2020 | 8.75M | +44.2% |
| 2019 | 6.07M | -35.5% |
| 2018 | 9.40M | +7.9% |
| 2017 | 8.72M | +90.1% |
| 2016 | 4.59M | +0.0% |
| 2015 | 4.59M | -96.7% |
| 2014 | 139.30M | +16.2% |
| 2013 | 119.89M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.54M | +0.0% | +0.0% |
| June 30, 2025 | 1.54M | +0.1% | +0.0% |
| March 31, 2025 | 1.54M | +0.1% | +0.0% |
| December 31, 2024 | 1.54M | +0.1% | +0.0% |
| September 30, 2024 | 1.54M | +0.6% | +0.1% |
| June 30, 2024 | 1.54M | +0.6% | +0.0% |
| March 31, 2024 | 1.54M | -89.8% | +0.0% |
| December 31, 2023 | 1.54M | +1.6% | +0.5% |
- Xenetic Biosciences, Inc. showed an increase of +48.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2013–2025 period, Xenetic Biosciences, Inc.’s shares outstanding has declined by 98.1% (from 119.89 million shares to 2.29 million shares).
- The most recent figure is from Xenetic Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: